Announced
Completed
CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics.
Financials
Transaction Value£92m
Consideration TypeCash
Capital Owned-
Capital Bid For-
EV/Sales-
EV/EBITDA-
Share Price Premium-
One Off Charge-
Sources
Tags
China
Friendly
Minority
medtech
Medical Services
Private Equity
Acquisition
Completed
Venture Capital
Domestic
Private
Synopsis
CPE, China Life Investment Management and Fortune Capital led a $126m Series C funding round in SiBionics, a medtech firm, with participation from China Life, Qianhai FOF, C&D, JD Invesment, Jingming Capital, Lucion, Source Code Capital, Cedarlake Capital and Riverhead Capital.
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.